DOI:

EAPCI, EuroIntervention and EuroPCR... together

William Wijns*, President, EAPCI

A new beginning

For many of you attending the EuroPCR this year the big difference will be the country we are meeting in. For the first time in the history of this scientific gathering we will be leaving France and heading for Spain and Barcelona. But for us, the EuroPCR has another aspect, one which sets it apart from all previous years, because this year it is OUR meeting as well.

We have said this many times before, but it values repeating: the EAPCI, the direct outgrowth of all our collaborative efforts – whether on the WG10, or in our national meetings throughout Europe, or in the EuroPCR itself – has been created as the next step in the evolution of our profession. From now on, and since our official founding last year at the ESC meeting, through our collaboration with this journal and the EuroPCR, we are all intimately connected – a symbiotic relationship that will only help progress our speciality.

A common goal

In a recent interview, Jean Fajadet, whose specific role as the current chair of our international affairs and national societies committee is to “facilitate and optimize the communication between EAPCI and all national interventional cardiology working groups”, underlined our efforts. A key element in our founding philosophy is our dedication to building close collaborative relationships between ourselves and all national groups through formal and direct contact. The goal is simple, we need to incite, inspire and encourage active involvement by these national working groups with the EuroPCR and the annual meeting of EAPCI in order to be the vital organisation that we set out to be.

We must remember that the EAPCI welcomes all professionals whose main activity is percutaneous cardiovascular interventions and who want to participate in our common goals of clinical research, scientific activities, and education in order to improve interventional procedures and the quality of patient care. As an example of this, Jean points to such activities as the successful (and oversubscribed!) Fellows course run last November in London by Carlo di Mario and George Dangas which offered preparation for future European certification exams in interventional cardiology.

More information on all our various activities can be found on our website at: www.escardio.org/bodies/associations/EAPCI

You make the difference

It is clear for those of us already active in the EAPCI that the difference is you, the individual practitioner. We are committed to building our speciality together, and your participation, whether on a local level, in our European-wide registries or meetings are crucial for all of us. It is for these reasons that the program of the EAPCI is of such seminal importance at this year’s EuroPCR, because it underlines the reality of this new dynamic.

We look forward to your joining us there.

Highlights of these meeting include:

Update on EuroHeart Survey and European registries

Tuesday, the 22nd May

16:30-18:30 in room 5

ESC@EuroPCR - the first disclosure of the new ESC guidelines on treatment of non- STEMI

Wednesday, the 23rd May

18:00-19:30 in room 5

EAPCI General Assembly

Thursday, the 24th May

18:00-19:30 in room 5

Awards ceremony – EAPCI Fellowship awards

to be presented by Antoine Lafont.

Friday, the 25th May - 12:00-12:30 in room 1

Volume 3 Number 1
May 22, 2007
Volume 3 Number 1
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00601 Jun 15, 2026
Unloading the clock: when timing meets physiology in STEMI shock
Møller J and Schrage B
free

Editorial

10.4244/EIJ-D-26-00394 Jun 15, 2026
Transcatheter edge-to-edge repair for primary mitral regurgitation: what lies ahead?
Petronio A and Mazzola M
free

Original Research

10.4244/EIJ-D-25-01308 Jun 15, 2026
Temporal trends in mitral edge-to-edge repair for primary mitral regurgitation
Koell B et al

Flashlight

10.4244/EIJ-D-25-01353 Jun 15, 2026
Transcatheter approximation of papillary muscles
Tekieli L et al
open access

Editorial

10.4244/EIJ-D-26-00479 Jun 1, 2026
Valve thrombosis or valve deterioration: what truly drives the prognosis?
Waksman R and Phichaphop A
free
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved